Faruqi & Faruqi Reminds Medpace Investors of Securities Class Action Deadline on June 8, 2026
Faruqi & Faruqi, LLP is reminding investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against Medpace (MEDP). The lawsuit alleges that Medpace provided misleading information about its backlog cancellation rates, leading to a significant stock price decline after the company reported a lower-than-expected book-to-bill ratio.
Tickers: $MEDP
Topics: book-to-bill ratio class action false statements investor rights securities litigation stock price decline